🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/07/2015 | 61,16 | 62,14 | 60,74 | 61,92 | +2,47% | 2,29% | 597.598 |
| 08/07/2015 | 60,62 | 61,86 | 60,25 | 60,43 | -0,80% | 2,66% | 655.627 |
| 07/07/2015 | 61,67 | 61,90 | 59,43 | 60,92 | -1,29% | 4,01% | 794.287 |
| 06/07/2015 | 61,02 | 62,51 | 60,36 | 61,72 | +0,33% | 3,54% | 402.994 |
| 02/07/2015 | 60,41 | 61,55 | 59,97 | 61,51 | +1,56% | 2,61% | 389.850 |
| 01/07/2015 | 63,15 | 63,40 | 59,91 | 60,57 | -3,78% | 5,53% | 660.596 |
| 30/06/2015 | 61,19 | 63,31 | 61,15 | 62,94 | +4,24% | 3,53% | 875.879 |
| 29/06/2015 | 61,59 | 63,63 | 60,17 | 60,39 | -2,53% | 5,61% | 711.411 |
| 26/06/2015 | 62,99 | 63,78 | 61,76 | 61,95 | -1,40% | 3,21% | 1.169.709 |
| 25/06/2015 | 62,20 | 62,89 | 61,02 | 62,83 | +1,55% | 3,01% | 521.456 |
| 24/06/2015 | 62,04 | 62,52 | 61,68 | 61,87 | -0,33% | 1,36% | 1.037.622 |
| 23/06/2015 | 61,55 | 62,28 | 61,35 | 62,08 | +0,73% | 1,50% | 777.134 |
| 22/06/2015 | 60,42 | 61,92 | 59,18 | 61,63 | +2,72% | 4,52% | 647.452 |
| 19/06/2015 | 60,03 | 61,11 | 58,72 | 59,99 | +0,40% | 3,98% | 1.278.393 |
| 18/06/2015 | 57,42 | 60,04 | 57,33 | 59,76 | +4,88% | 4,72% | 643.605 |
| 17/06/2015 | 56,99 | 58,82 | 56,61 | 56,97 | +0,68% | 3,89% | 781.783 |
| 16/06/2015 | 56,63 | 57,59 | 55,92 | 56,59 | +0,48% | 2,95% | 612.827 |
| 15/06/2015 | 56,03 | 57,75 | 55,31 | 56,32 | -3,89% | 4,36% | 1.063.591 |
| 12/06/2015 | 58,10 | 59,61 | 57,45 | 58,60 | -0,24% | 3,70% | 538.929 |
| 11/06/2015 | 58,86 | 59,53 | 57,27 | 58,74 | +1,01% | 3,85% | 755.654 |
| 10/06/2015 | 58,02 | 58,86 | 56,84 | 58,15 | +0,34% | 3,48% | 742.830 |
| 09/06/2015 | 59,17 | 60,48 | 56,36 | 57,95 | -2,54% | 6,96% | 1.156.565 |
| 08/06/2015 | 59,26 | 60,19 | 58,70 | 59,46 | +1,33% | 2,51% | 603.049 |
| 05/06/2015 | 57,63 | 59,23 | 56,49 | 58,68 | +3,00% | 4,75% | 725.037 |
| 04/06/2015 | 56,96 | 58,00 | 56,01 | 56,97 | -0,23% | 3,50% | 586.538 |
| 03/06/2015 | 53,46 | 57,36 | 53,17 | 57,11 | +8,13% | 7,83% | 1.301.315 |
| 02/06/2015 | 53,76 | 54,38 | 52,60 | 52,81 | -2,36% | 3,31% | 1.347.802 |
| 01/06/2015 | 54,41 | 54,99 | 52,63 | 54,09 | -1,59% | 4,35% | 788.195 |
| 29/05/2015 | 54,99 | 55,35 | 54,00 | 54,97 | -0,05% | 2,46% | 376.384 |
| 28/05/2015 | 54,14 | 55,06 | 52,75 | 54,99 | +1,02% | 4,26% | 545.341 |